We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ceramic Filter Could Transform Dialysis

By HospiMedica staff writers
Posted on 16 Apr 2007
A new, nano-porous ceramic filter offers patients the first major breakthrough in dialysis in the past 30 years.

The new ceramic filter has the potential to make kidney dialysis much more efficient, reducing the time required for a dialysis treatment by 30-60 minutes. More...
Specifically, the new filter promises to double the amount of toxins removed during dialysis and to double the glomulellar filtration rate (GFR), or rate of toxin removal. GFR is 100% in a normal person but only 15% at best for a dialysis patient, a rate that has changed little in the past 30 years.

The ceramic filter's secret lies in its pores, which are organized in orderly rows and columns and which measure mere nanometers in diameter. These nanopores correspond more closely to the nano-sized toxins in the blood than do the larger pores of the standard dialysis filter. The polymeric pores vary in size, and when viewed with a microscope, appear in random arrangements of ovals, circles, slits, and other shapes. The ceramic filter is under development at EMV Technologies (Bethlehem, PA, USA).

"Our goal is to double the amount of toxins removed during dialysis and to double GFR,” said the filter's developer William Van Geertruyden, Ph.D. "We base our confidence on the superior porosity of our medium. If we can improve the efficiency of filtration, we can improve mortality rate and quality of life.”

The new filter could also alleviate the stress resulting from the fast blood flow required to remove toxins and finish a dialysis treatment in four hours. Using the new filter will reduce the strain on hospitals and clinics equipped to do dialysis.


Related Links:
EMV Technologies

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.